메뉴 건너뛰기




Volumn 20, Issue 1 B, 2000, Pages 485-491

Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: A phase II study of the Italian Sarcoma Group (ISG)

Author keywords

Chemotherapy; Dose intensity; Liposomal doxorubicin; Soft tissue sarcomas

Indexed keywords

ANTHRACYCLINE; ANTIEMETIC AGENT; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; LIPOSOME;

EID: 0034109686     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (51)

References (36)
  • 2
    • 0031066347 scopus 로고    scopus 로고
    • Chemotherapy for adult soft tissue sarcoma: Does it work?
    • Saeter G: Chemotherapy for adult soft tissue sarcoma: does it work? Acta Orthop Scand 273: 139-144, 1997.
    • (1997) Acta Orthop Scand , vol.273 , pp. 139-144
    • Saeter, G.1
  • 3
    • 0026521884 scopus 로고
    • Doxorubicin (or epidoxorubicin) combined with ifosfamide in the treatment of adult soft tissue sarcomas
    • Toma S, Palumbo R, Sogno G, Venturino A, Santi L: Doxorubicin (or epidoxorubicin) combined with ifosfamide in the treatment of adult soft tissue sarcomas. Ann Oncol 3 (Suppl. 2): 119-123, 1992.
    • (1992) Ann Oncol , vol.3 , Issue.2 SUPPL. , pp. 119-123
    • Toma, S.1    Palumbo, R.2    Sogno, G.3    Venturino, A.4    Santi, L.5
  • 6
    • 0029164860 scopus 로고
    • Results of single agents and combination chemotherapy for advanced soft tissue sarcomas. Implications for decision making in the clinic
    • Sarcomas
    • Demetri GD, Elias AD: Results of single agents and combination chemotherapy for advanced soft tissue sarcomas. Implications for decision making in the clinic. Sarcomas, Pt. II. Hematol Oncol Clin North Am 9: 765-785, 1995.
    • (1995) Hematol Oncol Clin North Am , vol.9 , Issue.2 PART , pp. 765-785
    • Demetri, G.D.1    Elias, A.D.2
  • 7
    • 0030885437 scopus 로고    scopus 로고
    • A phase I/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced Soft tissue sarcomas
    • Bokemeyer C, Franzke A, Hartmann J, Schober C, Arseniev L, Metzner B, Link H, Kanz L, Schmoll HJ: A phase I/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced Soft tissue sarcomas. Cancer 80: 1221-1227, 1997.
    • (1997) Cancer , vol.80 , pp. 1221-1227
    • Bokemeyer, C.1    Franzke, A.2    Hartmann, J.3    Schober, C.4    Arseniev, L.5    Metzner, B.6    Link, H.7    Kanz, L.8    Schmoll, H.J.9
  • 8
    • 0030957418 scopus 로고    scopus 로고
    • Increasing 4'-epidoxorubicin and fixed ifosfamide doses plus granulocyte-macrophage colony-stimulating factor in advanced Soft Tissue Sarcomas: A pilot study
    • Frustaci S, Buonadonna A, Galligioni E, Favaro D, De Paoli A, Lo Re G, Sorio R, Tumolo S, Monfardini S: Increasing 4'-epidoxorubicin and fixed ifosfamide doses plus granulocyte-macrophage colony-stimulating factor in advanced Soft Tissue Sarcomas: a pilot study. J Clin Oncol 15: 1418-1426, 1997.
    • (1997) J Clin Oncol , vol.15 , pp. 1418-1426
    • Frustaci, S.1    Buonadonna, A.2    Galligioni, E.3    Favaro, D.4    De Paoli, A.5    Lo Re, G.6    Sorio, R.7    Tumolo, S.8    Monfardini, S.9
  • 9
    • 0344110204 scopus 로고    scopus 로고
    • Dose-intensive chemotherapy with Ifosfamide, Epirubicin, and filgastrim for adult patients with metastatic or locally advanced Soft Tissue Sarcoma: A phase II study
    • Reichardt P, Tilgner J, Hohenberger P, Dorken B: Dose-intensive chemotherapy with Ifosfamide, Epirubicin, and filgastrim for adult patients with metastatic or locally advanced Soft Tissue Sarcoma: a phase II study. J Clin Oncol 16: 1438-1443, 1998.
    • (1998) J Clin Oncol , vol.16 , pp. 1438-1443
    • Reichardt, P.1    Tilgner, J.2    Hohenberger, P.3    Dorken, B.4
  • 10
    • 0031687359 scopus 로고    scopus 로고
    • Phase I multicenter study of combined high-dose ifosfamide and doxorubicin in the treatment of advanced sarcomas
    • Leyvraz S, Bacchi M, Cerny T, Lissoni A, Sessa C, Bressoud A, Hermann R: Phase I multicenter study of combined high-dose ifosfamide and doxorubicin in the treatment of advanced sarcomas. Ann Oncol 9: 877-884, 1998.
    • (1998) Ann Oncol , vol.9 , pp. 877-884
    • Leyvraz, S.1    Bacchi, M.2    Cerny, T.3    Lissoni, A.4    Sessa, C.5    Bressoud, A.6    Hermann, R.7
  • 11
    • 0033036527 scopus 로고    scopus 로고
    • Dose-intensive first-line chemotherapy with epirubicin and continuous infusion ifosfamide in adult patients with advanced soft Tissue Sarcomas: A phase II study
    • Palumbo R, Neumaier C, Cosso M, Bertero G, Raffo P, Spadini N, Valente S, Villani G, Pastorino M, Toma S: Dose-intensive first-line chemotherapy with epirubicin and continuous infusion ifosfamide in adult patients with advanced soft Tissue Sarcomas: a phase II study. Eur J Cancer 35: 66-72, 1999.
    • (1999) Eur J Cancer , vol.35 , pp. 66-72
    • Palumbo, R.1    Neumaier, C.2    Cosso, M.3    Bertero, G.4    Raffo, P.5    Spadini, N.6    Valente, S.7    Villani, G.8    Pastorino, M.9    Toma, S.10
  • 12
    • 0027256397 scopus 로고
    • Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin and cisplatin against advanced soft tissue sarcomas
    • Edmonson JK, Ryan LM, Blum RH, Brooks JS, Shiraki M, Grytak S, Parkinson DR: Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin and cisplatin against advanced soft tissue sarcomas. J Clin Oncol 11: 1269-1275, 1993.
    • (1993) J Clin Oncol , vol.11 , pp. 1269-1275
    • Edmonson, J.K.1    Ryan, L.M.2    Blum, R.H.3    Brooks, J.S.4    Shiraki, M.5    Grytak, S.6    Parkinson, D.R.7
  • 13
    • 0029061785 scopus 로고    scopus 로고
    • Needed: Qualitative improvement in antisarcoma therapy
    • Edmonson JH: Needed: qualitative improvement in antisarcoma therapy. J Clin Oncol 13: 1531-1533, 1997.
    • (1997) J Clin Oncol , vol.13 , pp. 1531-1533
    • Edmonson, J.H.1
  • 14
    • 0029005580 scopus 로고
    • Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced Soft Tissue Sarcomas: A randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
    • Santoro A, Tursz T, Mouridsen H, Verweij J, Steward W, Somers R, Buesa J, Casali P, Spooner D, Rankin E, Kirkpatrick A, Van Glabbeke M, van Oosterom: Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced Soft Tissue Sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol 13: 1537-1545, 1995.
    • (1995) J Clin Oncol , vol.13 , pp. 1537-1545
    • Santoro, A.1    Tursz, T.2    Mouridsen, H.3    Verweij, J.4    Steward, W.5    Somers, R.6    Buesa, J.7    Casali, P.8    Spooner, D.9    Rankin, E.10    Kirkpatrick, A.11    Van Glabbeke, M.12    Van Oosterom13
  • 15
    • 0028875404 scopus 로고
    • Soft tissue sarcoma - Messages from completed randomsied trials
    • Gortzak E, van Coevorden F: Soft tissue sarcoma - Messages from completed randomsied trials. Eur J Surg Oncol 21: 469-477, 1995.
    • (1995) Eur J Surg Oncol , vol.21 , pp. 469-477
    • Gortzak, E.1    Van Coevorden, F.2
  • 19
    • 0027465117 scopus 로고
    • Granulocyte-macrophage colony-stimulating factor allows safe escalation of dose-intensity of chemotherapy in metastatic adult soft tissue sarcoma: A study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
    • Steward WP, Verweij J, Somers R, Spooner D, Kerbrat O, Clavel M, Crowther D, Rousse J, Tursz T, Tueni E: Granulocyte-macrophage colony-stimulating factor allows safe escalation of dose-intensity of chemotherapy in metastatic adult soft tissue sarcoma: A study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol 11: 15-21, 1993.
    • (1993) J Clin Oncol , vol.11 , pp. 15-21
    • Steward, W.P.1    Verweij, J.2    Somers, R.3    Spooner, D.4    Kerbrat, O.5    Clavel, M.6    Crowther, D.7    Rousse, J.8    Tursz, T.9    Tueni, E.10
  • 20
    • 0020467212 scopus 로고
    • Liposomes as in vivo carriers of adriamycin: Reduced cardiac uptake and preserved antitumor activity in mice
    • Gabizon A, Dagan A, Goren D, Barenholz Y, Fuks Z: Liposomes as in vivo carriers of adriamycin: reduced cardiac uptake and preserved antitumor activity in mice. Cancer Res 42: 4734-4739, 1982.
    • (1982) Cancer Res , vol.42 , pp. 4734-4739
    • Gabizon, A.1    Dagan, A.2    Goren, D.3    Barenholz, Y.4    Fuks, Z.5
  • 22
    • 0343084496 scopus 로고
    • Dose escalation of liposome-encapsulated doxorubicin (D-99) with granulocyte colony stimulating factor (G-CSF) support in patients with advanced malignancies
    • abstract
    • O'Days SJ, Mazanet R, Skarin AT, Salgia R, Gordon D, Elias AD: Dose escalation of liposome-encapsulated doxorubicin (D-99) with granulocyte colony stimulating factor (G-CSF) support in patients with advanced malignancies. Proc Am Soc Clin Oncol 13: 153, 1994 (abstract).
    • (1994) Proc Am Soc Clin Oncol , vol.13 , pp. 153
    • O'Days, S.J.1    Mazanet, R.2    Skarin, A.T.3    Salgia, R.4    Gordon, D.5    Elias, A.D.6
  • 23
    • 0343084497 scopus 로고    scopus 로고
    • Early results of a phase II study of liposomal doxorubicin (Doxil) in refractory sarcoma
    • abstract
    • Skubitz KM: Early results of a phase II study of liposomal doxorubicin (Doxil) in refractory sarcoma. Proc Am Soc Clin Oncol 16: 508, 1997 (abstract).
    • (1997) Proc Am Soc Clin Oncol , vol.16 , pp. 508
    • Skubitz, K.M.1
  • 24
    • 0030994523 scopus 로고    scopus 로고
    • Phase I trial of dose-intense liposome-encapsulated doxorubicin in patients with advanced sarcoma
    • Casper ES, Schwartz GK, Sugarman A, Leung D, Brennan MF: Phase I trial of dose-intense liposome-encapsulated doxorubicin in patients with advanced sarcoma. J Clin Oncol 15: 2111-2117, 1997.
    • (1997) J Clin Oncol , vol.15 , pp. 2111-2117
    • Casper, E.S.1    Schwartz, G.K.2    Sugarman, A.3    Leung, D.4    Brennan, M.F.5
  • 26
    • 0031795043 scopus 로고    scopus 로고
    • A phase II study of Doxil (liposomal doxorubicin): Lack of activity in poor prognosis soft tissue sarcomas
    • Garcia AA, Kempf RA, Rogers M, Muggia FM: A phase II study of Doxil (liposomal doxorubicin): lack of activity in poor prognosis soft tissue sarcomas. Ann Oncol 9: 1131-1133, 1998.
    • (1998) Ann Oncol , vol.9 , pp. 1131-1133
    • Garcia, A.A.1    Kempf, R.A.2    Rogers, M.3    Muggia, F.M.4
  • 27
  • 29
    • 0005755484 scopus 로고    scopus 로고
    • Liposomal doxorubicin (Caelyx) in advanced pretreated Soft Tissue Sarcomas (STS): A phase II trial of the Italian Sarcoma Group (ISG)
    • abstract
    • Toma S, Tucci A, Villani G, Carteni G, Palumbo R: Liposomal doxorubicin (Caelyx) in advanced pretreated Soft Tissue Sarcomas (STS): a phase II trial of the Italian Sarcoma Group (ISG). Proc Am Soc Clin Oncol 18: 540, 1999 (abstract).
    • (1999) Proc Am Soc Clin Oncol , vol.18 , pp. 540
    • Toma, S.1    Tucci, A.2    Villani, G.3    Carteni, G.4    Palumbo, R.5
  • 31
    • 0013170748 scopus 로고    scopus 로고
    • A phase II trial of Pegylated Liposomal Doxorubicin (Doxil) demonstrates activity in refractory sarcoma, mesothelioma, and head and neck cancer
    • abstract
    • Skubitz KM: A phase II trial of Pegylated Liposomal Doxorubicin (Doxil) demonstrates activity in refractory sarcoma, mesothelioma, and head and neck cancer. Proc Am Soc Clin Oncol 18: 541, 1999 (abstract).
    • (1999) Proc Am Soc Clin Oncol , vol.18 , pp. 541
    • Skubitz, K.M.1
  • 32
    • 0030824158 scopus 로고    scopus 로고
    • Should high-dose chemotherapy be used in the treatment of Soft Tissue Sarcoma?
    • Reichardt P, Verweij J, Crowther D: Should high-dose chemotherapy be used in the treatment of Soft Tissue Sarcoma? Eur J Cancer 33: 1351-1360, 1997.
    • (1997) Eur J Cancer , vol.33 , pp. 1351-1360
    • Reichardt, P.1    Verweij, J.2    Crowther, D.3
  • 33
    • 0031925278 scopus 로고    scopus 로고
    • High-dose therapy for adult Soft Tissue Sarcomas: Dose response and survival
    • Elias AD: High-dose therapy for adult Soft Tissue Sarcomas: dose response and survival. Semin Oncol 25: 19-23, 1998.
    • (1998) Semin Oncol , vol.25 , pp. 19-23
    • Elias, A.D.1
  • 35
    • 0032952928 scopus 로고    scopus 로고
    • Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcomas: An analysis of 2,185 patients treated with anthracycline-containing first-line regimens - A European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group study
    • Van Glabbeke M, van Oosterom AT, Oosterhuis JW, Mouridsen H, Crowther D, Somers R, Verweij J, Santoro A, Buesa J, Turs T: Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcomas: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens - A European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group study. J Clin Oncol 17: 150-157, 1999.
    • (1999) J Clin Oncol , vol.17 , pp. 150-157
    • Van Glabbeke, M.1    Van Oosterom, A.T.2    Oosterhuis, J.W.3    Mouridsen, H.4    Crowther, D.5    Somers, R.6    Verweij, J.7    Santoro, A.8    Buesa, J.9    Turs, T.10
  • 36
    • 17744412224 scopus 로고    scopus 로고
    • The outcome of advanced Soft Tissue sarcoma patients with complete tumour regression after either chemotherapy alone or chemotherapy plus surgery
    • The Scandinavian Sarcoma Group Experience
    • Wiklund T, Saeter G, Strander H, Alvegard T, Blomqvist C: The outcome of advanced Soft Tissue sarcoma patients with complete tumour regression after either chemotherapy alone or chemotherapy plus surgery. The Scandinavian Sarcoma Group Experience. Eur J Cancer 33: 357-361, 1997.
    • (1997) Eur J Cancer , vol.33 , pp. 357-361
    • Wiklund, T.1    Saeter, G.2    Strander, H.3    Alvegard, T.4    Blomqvist, C.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.